Skip to Main content Skip to Navigation
New interface
Journal articles

No loss of sst receptors gene expression in advanced stages of colorectal cancer.

Abstract : As demonstrated by several studies, the pan-inhibitory peptide somatostatin (SS) is implicated in a large variety of physiological processes in the gastrointestinal tractus. SS inhibits hormonal and gastric acid secretions, and decreases gastric and intestinal motility, mesenteric blood flow and intestinal absorption. In vitro and in vivo studies showed also that the antiproliferative potency of SS analogs may be a target to improve the prognosis of colorectal cancer. Here we report the expression profile of the five SS receptor subtypes (hsst1-5) mRNAs in a large set of tumoral and normal colon. Using reverse transcription-PCR, we showed that hsst5, hsst1 and hsst2 mRNA subtypes were the most frequently expressed hsst mRNA subtypes in normal and pathological colon. Interestingly, we found that the frequency of hsst5 mRNA expression in the left colon was significantly higher in tumors than in normal samples: 81. 2% (13/16) and 36.4% (4/11) respectively (0.025>P>0.01, chi2 test with Yates' correction). We did not find any influence of Dukes' stage on hsst mRNAs expression. Of interest, no loss of hsst2 and hsst5 mRNA expression in advanced stages was noted. Some differences in the frequency of expression of hsst mRNAs according to the origin of the tissue (left or right colon) were evident. The expression of hsst5 and hsst2 mRNA in advanced colorectal carcinoma associated with the development of new SS analogs boost the relevance of colorectal cancer treatment by somatostatin analogs.
Document type :
Journal articles
Complete list of metadata
Contributor : L'Houcine Ouafik Connect in order to contact the contributor
Submitted on : Thursday, June 21, 2018 - 2:10:41 PM
Last modification on : Tuesday, November 16, 2021 - 3:21:39 AM

Links full text




V Vuaroqueaux, A. Dutour, Nathalie Briard, M Monges, M. Grino, et al.. No loss of sst receptors gene expression in advanced stages of colorectal cancer.. European Journal of Endocrinology, 1999, 140 (4), pp.362-6. ⟨10.1530/eje.0.1400362⟩. ⟨hal-01820263⟩



Record views